Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 59:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004049 AN006694 Comparison of lipidome from phagosomes containing Pam3csk4-beads vs. uncoupled-beads Macrophages Mouse St Jude Children's Research Hospital LC-MS
ST003776 AN006202 Investigation of Hepatic Lipid Alterations Following Micro- and Nanoplastic-Ingestion Liver Mouse Environmental exposure University of Bonn LC-MS
ST003702 AN006074 Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion using Csf1r conditional KO Liver Mouse University of Bonn LC-MS
ST003614 AN005939 Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion Liver Mouse University of Bonn LC-MS
ST003220 AN005280 Obesity, sex, and depot drive distinct lipid profiles in murine white adipose tissue Adipose tissue Mouse Obesity University of Utah LC-MS
ST003157 AN005179 Diet modulates the protective effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCA2 - Lipidomics Blood Mouse Multiple sclerosis University of Luebeck LC-MS
ST003051 AN005002 Shotgun lipidomics of breast cancer endocrine therapy persisters Breast cancer cells Human Cancer Dartmouth College LC-MS
ST002070 AN003374 Lipidomic Comparison of 2D and 3D Colon Cancer Cell Culture Models Cultured cells Human Cancer Ohio State University LC-MS
ST001989 AN003241 THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 3) LNCaP cells Human Cancer IGMM LC-MS
ST001988 AN003240 THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 2) LNCaP cells Human Cancer IGMM LC-MS
ST001363 AN002269 Monophasic lipidomics extraction in cancer cell lines Hep G2 cells Human Cancer Institute of Genetics and Molecular Medicine LC-MS
ST000917 AN001500 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine Urine Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000915 AN001488 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000775 AN001225 Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study Blood Human Depression University of Michigan LC-MS
ST000665 AN001017 Nonalcoholic fatty liver disease (NAFLD) Studies Cultured cells Human Fatty liver disease University of Michigan LC-MS
ST000664 AN001015 Nutritional Psychiatric Illness Studies Blood Human Bipolar I Disorder University of Michigan LC-MS
ST000662 AN001011 Lipidomics of hormone-sensitive lipase variants Adipose tissue Human University of Michigan LC-MS
ST000661 AN001009 CHOICE clinical weight loss study Blood Human Obesity University of Michigan LC-MS
ST000661 AN001009 CHOICE clinical weight loss study Blood Rat Obesity University of Michigan LC-MS
ST000114 AN000192 SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium B-cells Human Cancer University of Kentucky GC-MS/LC-MS
ST000005 AN000012 Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin Macrophages Mouse LIPID MAPS GC-MS/LC-MS
  logo